Clinical Trials Logo
  1. Home
  2. Metabolic Disturbance
  3. NCT05454943

Remote Time-restricted EAting DeliverY — READY  

Metabolic Disturbance Clinical Trial

Official title:
Proof-of-Concept of Time-Restricted Eating as a Novel Lifestyle Intervention for Breast Cancer Prevention

Clinical Trial Summary

This study will evaluate the implementation and effectiveness of free-living TRE on biological and behavioural breast cancer risk factors.

Clinical Trial Description

TRE is an eating pattern where individuals consume ad libitum energy intake within a set window of time, commonly 8 hours, which induces a fasting window of 16 hours per day (i.e., 16:8 TRE). TRE is a simple and accessible lifestyle intervention with high adherence potential that may target both biological and behavioural mechanisms of breast cancer risk. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05454943
Study type Interventional
Source University of Toronto
Contact
Status Active, not recruiting
Phase N/A
Start date July 7, 2022
Completion date December 6, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04528004 - Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure Early Phase 1
Completed NCT04597983 - Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists N/A
Completed NCT03445234 - Blueberries, Bananas, Exercise Recovery N/A
Recruiting NCT04892199 - Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Phase 4
Active, not recruiting NCT05070585 - Isothiocyanates and Metabolic Health Phase 1/Phase 2
Not yet recruiting NCT05494151 - Metabolic Substrate of Patients With Myocardial Infarction With and Without Modifiable Cardiovascular Risk Factors
Completed NCT04787952 - Insight Into New Brown Adipose Tissue Activators.
Completed NCT05758857 - Multiple Risk Factor Intervention Trial N/A
Completed NCT02689882 - "Pharmacokinetic Study of Nicotinamide Riboside" Phase 1
Completed NCT01674426 - Pathogenesis of Functional Hypothalamic Amenorrhea N/A
Recruiting NCT06252922 - Diet-Induced Changes in GEnetic Material
Completed NCT06326840 - Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment N/A
Recruiting NCT06392360 - Betaine, Exercise Performance, and Gut Permeability N/A
Completed NCT04009642 - Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
Withdrawn NCT03515642 - Exercise, Gut Microbiota in Sedentary Adults With Overweight N/A
Recruiting NCT06333184 - Smoothies and Blood Sugars N/A
Not yet recruiting NCT05773183 - Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Completed NCT04266665 - Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome Phase 4
Completed NCT03697928 - Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability
Recruiting NCT04469790 - Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children N/A